ACM Research, Inc.
ACMR Nasdaq Special Industry Machinery, Nec Financials FY2016βFY2025
What ACM Research, Inc. does
No business description yet.
- Legal name
- ACM Research, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 2, 2026
- Accession Β· CIK
- 0001628280-26-013231
0001680062
Revenue and margins
ACM Research, Inc. had $901M of revenue in fiscal 2025, up 15.2% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 25.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$66.6M in fiscal 2025, β7.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
ACM Research, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 1.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably ACM Research, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $592M | $268M | $203M | $427M | $793M |
| Debt incl. finance leases | $35.0M | $77.0M | $92.1M | $183M | $288M |
| Net debt / EBITDA | β13.6x | β3.0x | β1.1x | β1.5x | β4.1x |
| Debt / equity | 0.1x | 0.1x | 0.1x | 0.2x | 0.2x |
| Interest coverage | 50.6x | 35.7x | 35.7x | 36.4x | 15.7x |
| Current ratio | 4.6x | 2.4x | 2.3x | 2.3x | 3.3x |
| Quick ratio | 3.6x | 1.4x | 1.3x | 1.4x | 2.3x |
| Total assets | $1.1B | $1.2B | $1.5B | $1.9B | $2.9B |
| Total liabilities | $241M | $423M | $565M | $760M | $942M |
| Shareholders' equity | $676M | $675M | $767M | $905M | $1.5B |
| Net debt (β = net cash) | β$557M | β$191M | β$111M | β$244M | β$505M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 2 / 9 | 5 / 9 | 6 / 9 | 1 / 9 | 3 / 9 | 4 / 9 | 6 / 9 | 6 / 9 | 2 / 9 |
| Accruals ratio | 10.6% | 13.9% | β0.4% | 5.9% | 11.6% | 11.2% | 8.9% | 11.2% | β2.9% | 4.4% |
| Altman Z'' | 3.15 | 5.05 | 4.57 | 6.84 | 4.90 | 8.05 | 5.26 | 5.17 | 5.23 | 6.15 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $27.4M | $36.5M | $74.6M | $108M | $157M | $260M | $389M | $558M | $782M | $901M |
| Net interest income | β$0.3M | β$0.8M | $1.3M | β | β | β | β | β | β | β |
| Gross profit | $13.3M | $17.2M | $34.4M | $50.7M | $69.6M | $115M | $184M | $276M | $392M | $400M |
| Research and development | $3.3M | $5.1M | $10.4M | $12.9M | $19.1M | $34.2M | $62.2M | $92.7M | $105M | $145M |
| Operating income | $3.5M | $0.7M | $6.5M | $17.8M | $21.5M | $38.7M | $59.0M | $95.8M | $151M | $109M |
| Interest expense | $0.2M | $0.3M | $0.5M | $0.7M | $1.0M | $0.8M | $1.7M | $2.7M | $4.2M | $7.0M |
| Pretax income | $3.0M | β$0.3M | $7.4M | $18.9M | $19.3M | $43.1M | $67.4M | $116M | $166M | $135M |
| Income tax | $0.6M | $0.5M | $0.8M | β$0.5M | β$2.4M | $0.1M | $16.8M | $19.4M | $35.0M | $13.3M |
| Net income | $1.0M | β$0.3M | $6.6M | $18.9M | $18.8M | $37.8M | $39.3M | $77.3M | $104M | $94.1M |
| Net income to common | $0.6M | β$0.3M | $6.6M | $18.9M | $18.8M | $37.8M | $39.3M | $77.3M | $104M | $94.1M |
| Diluted EPS | $0.18 | β$0.05 | $0.37 | $0.99 | $0.30 | $0.58 | $0.59 | $1.16 | $1.53 | $1.37 |
| Diluted shares | 0.00B | 0.01B | 0.02B | 0.02B | 0.06B | 0.07B | 0.07B | 0.06B | 0.07B | 0.07B |
| Cash flow | ||||||||||
| Cash from operations | β$3.7M | β$8.1M | $6.9M | $9.4M | β$13.5M | β$40.1M | β$62.2M | β$75.3M | $152M | β$10.3M |
| Capital expenditure | $0.8M | $0.7M | $1.8M | $1.0M | $5.2M | $9.2M | $91.1M | $61.9M | $82.5M | $56.3M |
| Free cash flow | β$4.5M | β$8.8M | $5.1M | $8.4M | β$18.8M | β$49.2M | β$153M | β$137M | $70.0M | β$66.6M |
| Depreciation and amortization | $0.2M | $0.3M | $0.4M | $0.8M | $1.1M | $2.4M | $4.8M | $6.9M | $6.6M | $14.4M |
| Stock-based compensation | $0.4M | $1.6M | $3.4M | $3.6M | $5.6M | $5.1M | $7.7M | $27.3M | $49.6M | $33.6M |
| Share buybacks | β | β | $0.0M | $2.8M | $0.0M | $0.0M | β | β | β | β |
| Dividends and buybacks | β | β | $0.0M | $2.8M | $0.0M | $0.0M | β | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $10.1M | $17.7M | $27.1M | $58.3M | $100M | $592M | $268M | $203M | $427M | $793M |
| Total debt | $4.8M | $5.1M | $9.4M | $13.8M | $45.7M | $35.0M | $77.0M | $92.1M | $183M | $288M |
| Current assets | $40.3M | $62.9M | $96.0M | $198M | $261M | $953M | $964M | $1.2B | $1.5B | $2.4B |
| Current liabilities | $17.1M | $21.8M | $46.1M | $53.5M | $103M | $206M | $396M | $501M | $641M | $746M |
| Inventory | $11.7M | $15.4M | $38.8M | $44.8M | $88.6M | $218M | $393M | $545M | $598M | $703M |
| Property and equipment, net | $2.3M | $2.3M | $3.7M | $3.6M | $8.2M | $14.0M | $82.9M | $202M | $269M | $315M |
| Intangible assets | $0.0M | $0.1M | $0.3M | $0.3M | $0.6M | $0.5M | $1.3M | $2.5M | $3.5M | $2.8M |
| Total assets | $44.5M | $67.9M | $103M | $218M | $341M | $1.1B | $1.2B | $1.5B | $1.9B | $2.9B |
| Total liabilities | $23.9M | $28.0M | $50.7M | $60.2M | $133M | $241M | $423M | $565M | $760M | $942M |
| Shareholders' equity | β$2.4M | $39.9M | $52.3M | $97.3M | $141M | $676M | $675M | $767M | $905M | $1.5B |
| Margins | ||||||||||
| Gross margin | 48.7% | 47.2% | 46.2% | 47.1% | 44.4% | 44.2% | 47.2% | 49.5% | 50.1% | 44.4% |
| Operating margin | 12.8% | 1.9% | 8.7% | 16.5% | 13.7% | 14.9% | 15.2% | 17.2% | 19.3% | 12.1% |
| EBITDA margin | 13.4% | 2.7% | 9.2% | 17.3% | 14.4% | 15.8% | 16.4% | 18.4% | 20.1% | 13.7% |
| Net margin | 3.8% | β0.9% | 8.8% | 17.6% | 12.0% | 14.5% | 10.1% | 13.9% | 13.2% | 10.4% |
| FCF margin | β16.4% | β24.0% | 6.8% | 7.8% | β12.0% | β19.0% | β39.4% | β24.6% | 8.9% | β7.4% |
| Net interest share of revenue | β1.3% | β2.2% | 1.7% | β | β | β | β | β | β | β |
| Returns | ||||||||||
| Return on capital | β | 2.0% | 16.6% | 33.7% | 24.7% | 32.4% | 9.2% | 12.2% | 18.0% | 10.3% |
| Return on capital employed | 12.7% | 1.5% | 11.4% | 10.8% | 9.0% | 4.6% | 7.0% | 9.7% | 12.4% | 5.1% |
| Return on equity | β | β1.7% | 14.3% | 25.3% | 15.8% | 9.2% | 5.8% | 10.7% | 12.4% | 7.9% |
| Return on assets | 2.3% | β0.6% | 7.7% | 11.8% | 6.7% | 5.4% | 3.4% | 5.7% | 6.2% | 4.0% |
| Return on tangible equity | β | β0.8% | 12.6% | 19.5% | 13.4% | 5.6% | 5.8% | 10.1% | 11.5% | 6.4% |
| Growth | ||||||||||
| Revenue growth | β | 33.4% | 104.5% | 44.1% | 45.7% | 65.8% | 49.7% | 43.4% | 40.2% | 15.2% |
| Net income growth | β | β130.8% | β | 187.4% | β0.6% | 101.0% | 4.0% | 97.0% | 34.0% | β9.2% |
| EPS growth | β | β127.8% | β | 167.6% | β69.7% | 93.3% | 1.7% | 96.6% | 31.9% | β10.5% |
| FCF growth | β | β | β | 66.0% | β322.5% | β | β | β | β | β195.2% |
| Share count change | β | 81.0% | 160.9% | 6.8% | 232.1% | 2.8% | β0.0% | β0.7% | 2.1% | 1.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | β1.5x | β13.0x | β2.6x | β2.4x | β2.4x | β13.6x | β3.0x | β1.1x | β1.5x | β4.1x |
| Debt / equity | β | 0.1x | 0.2x | 0.1x | 0.3x | 0.1x | 0.1x | 0.1x | 0.2x | 0.2x |
| Interest coverage | 19.3x | 2.5x | 13.0x | 23.9x | 21.9x | 50.6x | 35.7x | 35.7x | 36.4x | 15.7x |
| Current ratio | 2.4x | 2.9x | 2.1x | 3.7x | 2.5x | 4.6x | 2.4x | 2.3x | 2.3x | 3.3x |
| Quick ratio | 1.7x | 2.2x | 1.2x | 2.9x | 1.7x | 3.6x | 1.4x | 1.3x | 1.4x | 2.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.9% | 1.8% | 2.5% | 0.9% | 3.3% | 3.5% | 23.4% | 11.1% | 10.5% | 6.2% |
| Stock comp / revenue | 1.4% | 4.4% | 4.5% | 3.3% | 3.6% | 2.0% | 2.0% | 4.9% | 6.3% | 3.7% |
| Payouts / FCF | β | β | 0.0% | 33.5% | β | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 2.0 | 5.0 | 6.0 | 1.0 | 3.0 | 4.0 | 6.0 | 6.0 | 2.0 |
| Altman Z'' | 3.1 | 5.1 | 4.6 | 6.8 | 4.9 | 8.1 | 5.3 | 5.2 | 5.2 | 6.1 |
| Accruals ratio | 10.6% | 13.9% | β0.4% | 5.9% | 11.6% | 11.2% | 8.9% | 11.2% | β2.9% | 4.4% |
Source: SEC EDGAR XBRL filings (CIK 0001680062). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.